cap
communityacquir
pneumonia
cmv
convent
mechan
ventil
hap
hospitalacquir
pneumonia
hcap
healthcareassoci
pneumonia
niv
noninvas
ventil
ptc
protect
telescop
aspir
vap
ventilatorassoci
pneumonia
respiratori
failur
one
lead
admiss
diagnos
critic
care
unit
journal
reflect
past
month
understand
aetiolog
pulmonari
sepsi
import
choic
ventil
ga
humidif
system
propheci
pandem
panic
futil
surviv
gene
healthcareassoci
pneumonia
hcap
refer
pulmonari
infect
develop
individu
recent
hospitalis
undergo
renal
replac
therapi
longterm
outpati
care
past
year
postul
reflect
distinct
group
pathogen
consequ
implic
therapi
also
outcom
howev
studi
look
pathogen
hcap
communityacquir
pneumonia
cap
compar
hospitalacquir
pneumonia
hap
ventilatorassoci
pneumonia
vap
kollef
et
al
attempt
retrospect
analysi
larg
usa
databas
cultureposit
pneumonia
us
centr
period
studi
defin
posit
pneumonia
cap
hcap
hap
vap
result
show
patient
hcap
slightli
older
cap
broadli
similar
hap
half
patient
hcap
came
nurs
home
ill
sever
almost
ident
hcap
vap
higher
hap
cap
bacteri
pathogen
identif
show
high
rate
staphylococcu
aureu
infect
type
pneumonia
may
artefact
howev
also
interest
low
rate
pneumococc
infect
cap
overal
bacteri
speci
hcap
broadli
similar
hap
vap
pseudomona
account
methicillinresist
aureu
rest
made
usual
gramneg
type
also
note
patient
mortal
hcap
similar
hap
higher
cap
lower
vap
author
suggest
hcap
distinct
entiti
cap
treat
hospitalacquir
type
infect
first
present
paper
certainli
support
recent
publish
guidelin
american
thorac
societi
stay
pulmonari
sepsi
theme
lacherad
et
al
shed
light
debat
factor
may
influenc
develop
vap
particular
use
differ
humidif
devic
fivecentr
prospect
trial
randomis
unselect
patient
requir
ventil
hour
receiv
treatment
either
heat
humidifi
heat
moistur
exchang
stay
show
differ
treatment
incid
vap
given
previou
data
subject
increasingli
appear
mode
respiratori
ga
humidif
critic
optim
specimen
collect
techniqu
diagnosi
vap
continu
strongli
debat
paper
brunbuisson
et
al
look
patient
clinic
appar
vap
prospect
perform
blind
endotrach
aspir
blind
protect
telescop
aspir
ptc
bronchoscop
aspir
result
confirm
bronchoscop
aspir
provid
best
cultur
fewer
fals
posit
ptc
close
behind
howev
endotrach
aspir
produc
fals
posit
mean
use
ptc
use
obtain
specimen
diagnosi
vap
guid
therapi
avoid
need
invas
procedur
expens
equip
final
respiratori
theme
role
noninvas
ventil
niv
make
anoth
appear
paper
commentari
compar
role
niv
mechan
ventil
patient
acut
respiratori
failur
caus
fulfil
defin
criteria
convent
mechan
ventil
cmv
total
patient
randomis
niv
cmv
niv
group
convert
cmv
mortal
rate
niv
group
compar
cmv
group
complic
rate
durat
ventil
similar
also
show
patient
respond
niv
wors
overal
receiv
cmv
start
interest
find
patient
pneumonia
underw
niv
requir
cmv
find
consist
studi
identifi
accompani
editori
studi
number
small
particularli
given
allcaus
inclus
criteria
interpret
result
cautiou
world
recent
seem
ever
danger
place
increas
reason
troubl
apocalypt
nightmar
superbug
near
quit
sure
itand
probabl
tri
kill
given
half
chanc
methicillinvancomycinresist
aureu
sever
acut
respiratori
syndrom
pandem
avian
influenza
domin
medic
lay
press
anteced
organ
well
known
us
seem
start
take
steroid
go
gym
lot
mount
evid
clostridium
difficil
undergon
similar
process
c
difficil
sporeform
gramposit
anaerob
bacillu
recognis
caus
agent
antibioticassoci
coliti
sinc
given
appropri
alter
colon
flora
bacterium
replic
produc
endotoxin
classic
b
caus
spectrum
diseas
troublesom
wateri
diarrhoea
lifethreaten
pseudomembran
coliti
depend
larg
host
characterist
age
sever
underli
diseas
therefor
make
incid
intens
care
unit
particularli
high
furthermor
outbreak
larg
isol
individu
ward
institut
howev
recent
year
much
larger
outbreak
north
america
europ
suggest
increas
preval
resist
virul
c
difficil
rais
ugli
spectr
epidem
strain
lead
us
ask
occur
whether
spontan
genet
mutat
chang
medic
practic
whether
anyth
two
recent
publish
paper
accompani
editori
address
issu
work
mcdonald
et
al
consist
impress
detail
microbiolog
survey
c
difficil
outbreak
across
six
state
unit
state
genet
toxicolog
profil
compar
histor
databas
c
difficil
obtain
second
paper
research
group
quebec
perform
prospect
surveil
institut
determin
incid
hospitalacquir
c
difficileassoci
diarrhoea
associ
risk
factor
isol
also
type
result
two
studi
larg
corrobor
previous
uncommon
strain
c
difficil
markedli
increas
incid
characteris
product
new
toxin
binari
toxin
partial
delet
tcdc
gene
normal
downregul
toxin
b
product
increas
resist
fluoroquinolon
morbid
mortal
particularli
among
elderli
increas
compar
outbreak
risk
factor
includ
exposur
fluoroquinolon
cephalosprin
precis
scientif
link
suggest
virul
factor
binari
toxin
tcdc
partial
delet
sever
diseas
yet
made
emerg
rel
new
strain
c
difficil
concomit
increas
sever
preval
diseas
must
caus
concern
answer
question
accompani
editori
suggest
follow
essenti
continu
microbiolog
surveil
diseas
outbreak
along
earli
diagnosi
treatment
scrupul
infect
control
practic
beyond
normal
contact
risk
patient
use
soap
water
hand
wash
given
spore
resist
alcohol
prepar
regular
institut
review
antimicrobi
stewardship
earli
deescal
broadspectrum
antibiot
wherev
possibl
final
presum
kept
lancet
recent
hope
mitochondri
dna
haplogroup
h
varieti
group
newcastl
analys
mitochondri
dna
sequenti
adult
admiss
intens
care
unit
diagnosi
sever
sepsi
primari
outcom
measur
surviv
day
use
logist
regress
analysi
demonstr
haplogroup
h
independ
predictor
surviv
patient
haplogroup
h
confid
interv
time
like
aliv
day
author
propos
find
might
explain
enhanc
respiratori
chain
activ
associ
haplotyp
cite
cellular
dysoxia
secondari
mitochondri
dysfunct
key
factor
sepsisinduc
organ
dysfunct
interestingli
haplogroup
h
patient
gener
significantli
higher
temperatur
patient
differ
haplogroup
fortun
h
commonest
haplogroup
account
patient
studi
author
suggest
mitochondri
dna
haplotyp
offer
new
mean
risk
stratif
sever
sepsi
although
work
clearli
need
identifi
possibl
therapeut
avenu
author
declar
compet
interest
